Relapse yes (n = 31) | Relapse no (n = 117) | Significance | |
---|---|---|---|
Gender (♀); patients (%) | 20 (64.51) | 72 (61.53) | χ2 = 0.92, p = 0.761 |
Age (years); mean (SD) | 30.45 (± 7.66) | 38.02 (± 10.42) | t = − 3.77, p < 0.001 |
EDSS*; mean (SD) | 1.32 (± 0.83) | 1.55 (± 0.86) | t = − 1.34, p = 0.181 |
Enhancing lesions**; patients (%) | 18/31 (58) | 55/81 (67.9) | χ2 = 1.36, p = 0.243 |
Naïve Treg percentage*; mean (SD) | 33 (± 14) | 28.16 (± 11.09) | t = 2.03, p = 0.044 |
TregCM percentage*; mean (SD) | 42.63 (± 13.12) | 46.52 (± 8.17) | t = − 2.04, p = 0.043 |
TregEM percentage*; mean (SD) | 23.39 (± 6.28) | 25.06 (± 8.10) | t = 0.27, p = 0.290 |
Tr1 percentage*; mean (SD) | 3.83 (± 1.22) | 4.68 (± 2.13) | t =− 2.10, p = 0.037 |